Come up with a name for your new list and we'll add to it:
Savara raised a round of funding on April 20, 2012. Investors include
National Institutes of Health.
Savara (NASDAQ: SVRA) is a clinical-stage specialty pharmaceutical company focused on the development and commercialization of novel therapies for the treatment of serious or life-threatening rare res…